Since our previous studies showed that the p85α SH3 and BH domains are important for PTEN binding, and that p85α can upregulate PTEN lipid phosphatase activity11, these tumor-derived N-terminal p85α mutations may alter the binding and/or regulation of PTEN by p85α. This evidence concerns the gene PTEN and neoplasm.